- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Infliximab – November 2017
Infliximab: Powder for I.V. infusion 100 mg; Renflexis®
Last updated
2 March 2018